Leading the Way in Life Science Technologies

GEN Exclusives

More »

Apr. 15, Vol. 26, No. 8

    • Feature Articles

      • Access to Global Networks in Life Sciences
      • Networking is vital to biotech because companies can only grow and bring their products to market through developing the right contacts, alliances, and entrepreneurial skills. Additionally, as the business goes global, networking skills have never b ... more »
      • Achieving Seamless RNA Analysis
      • Good-quality RNA impacts downstream analysis and results, explains Lucy Sha, marketing director for gene and protein discovery at GE Healthcare (www.gehealthcare.com). &#8220Sample preparation is critical, and the entire process of RNA analysis ... more »
      • Market Increases Oligonucleotide Demands
      • Even as new players join the competitive market for research- and pharmaceutical-grade oligonucleotides, acquisitions and partnerships continue to change the face of the supplier landscape. Demand is driven by the established market for primers and ... more »
      • Microsoft Establishes the BioIT Alliance
      • Microsoft (www.microsoft.com) has formed the BioIT Alliance (www.bioitalliance.org), a cross-industry group that will focus on further integrating science and technology with the goal of making personalized medicine a reality. The alliance brings to ... more »
      • Peptide Drug Discovery Research Reenergized
      • Fail fast and fail cheap is the current mantra in drug discovery. This approach is based on the premise that elimination of high-risk compounds early in the discovery process increases the success rate of finding a new therapeutic drug. Also, compan ... more »
    • Tutorials

      • Assay: Microfluidic Capillary Electrophoresis
      • With the recent advances in genomics, combinatorial chemistry, and automation, drug discovery scientists working in pharmaceutical, biotechnology, and academic environments are faced with the overwhelming task of developing many new assays. These as ... more »
      • Bridging Biological Systems Knowledge Gaps
      • Knowledge of the molecular processes that constitute biological systems has grown explosively in recent years. Translating that knowledge into useful therapies, however, has fallen short of early expectations. Translational researchers confront a st ... more »
      • Glycosylation Patterns During Fermentation
      • Glycosylation is one of the most abundant of all protein post-translational modifications (PTMs). It results from the addition of sugar residues to protein sidechains to form a glycoprotein. Mammalian glycoprotein oligosaccharides are commonly built ... more »
    • Financial Focus

      • Isis Moves Ahead on Antisense Program
      • Querida Anderson
      • Isis Pharmaceuticals (www.isispharm.com) has developed an antisense drug candidate that continues to show potential in treating patients with cardiovascular diseases by reducing cholesterol, LDL-C, as well as triglyceride levels. Although excitement ... more »
    • Corporate Profile

      • Chemo-Proteomics Approach to Cancer
      • Many biopharmaceutical companies are seeking new anticancer treatments. Serenex (www.serenex.com) is among them. Its lead compound, SNX-1012, is a first-in-class therapy for oral mucositis, the most common debilitating side effect of chemotherapy an ... more »

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »